| __timestamp | Amgen Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 85181000 |
| Thursday, January 1, 2015 | 4070000000 | 135253000 |
| Friday, January 1, 2016 | 3840000000 | 162297000 |
| Sunday, January 1, 2017 | 3562000000 | 198442000 |
| Monday, January 1, 2018 | 3737000000 | 226616000 |
| Tuesday, January 1, 2019 | 4116000000 | 299726000 |
| Wednesday, January 1, 2020 | 4207000000 | 335375000 |
| Friday, January 1, 2021 | 4819000000 | 505748000 |
| Saturday, January 1, 2022 | 4434000000 | 590453000 |
| Sunday, January 1, 2023 | 4784000000 | 849658000 |
| Monday, January 1, 2024 | 5964000000 |
Data in motion
In the competitive landscape of pharmaceuticals, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Amgen Inc. and Jazz Pharmaceuticals plc have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, Amgen consistently allocated a significant portion of its resources to R&D, with expenditures peaking in 2021 at approximately 4.8 billion USD. This represents a 35% increase from its lowest point in 2017. In contrast, Jazz Pharmaceuticals, while smaller in scale, has shown a remarkable growth trajectory in R&D spending, increasing its investment by nearly tenfold from 2014 to 2023. This strategic focus underscores the importance of R&D in driving innovation and maintaining competitive advantage in the pharmaceutical industry. As these companies continue to evolve, their commitment to R&D will likely play a pivotal role in shaping their future success.
Comparing Innovation Spending: Amgen Inc. and Exelixis, Inc.
R&D Insights: How Amgen Inc. and Pharming Group N.V. Allocate Funds
Research and Development Expenses Breakdown: Amgen Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: Amgen Inc. and Ligand Pharmaceuticals Incorporated
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and Ultragenyx Pharmaceutical Inc. Allocate Funds
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG
Research and Development Investment: Jazz Pharmaceuticals plc vs HUTCHMED (China) Limited
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Geron Corporation
R&D Insights: How Jazz Pharmaceuticals plc and Taro Pharmaceutical Industries Ltd. Allocate Funds